UCIBIO
UCIBIO is an applied molecular biosciences research unit based in Caparica, Portugal, founded in 2015, that conducts interdisciplinary research in chemistry, biology, and engineering to address applied problems in the molecular biosciences.
- Company typePrivate
- Founded2015
- HeadquartersCaparica, Portugal
- Headcount51–100
- GTM typeB2B
- OfferingServices
What UCIBIO does
UCIBIO is an applied molecular biosciences research unit headquartered in Caparica, Portugal, founded in 2015. According to the available firmographic data, the unit conducts interdisciplinary research spanning chemistry, biology, and engineering to address applied problems in the molecular biosciences. The organization is classified as a for-profit entity with a headcount of 51-100 employees and operates privately. Its geographic base in Caparica — adjacent to Lisbon — is consistent with a research unit affiliated with or operating in proximity to a Portuguese university campus.
The input data provides no substantive information on UCIBIO's product portfolio, service offerings, technology stack, intellectual property, partnerships, customer base, pricing model, or revenue mechanics. The company website (ucibio.pt) was inaccessible during data collection, returning only a verification/loading page. All structured data fields relating to products, customers, funding, leadership, certifications, and operations are empty. As a result, the business model, go-to-market motion, and revenue drivers cannot be characterized from the available evidence. A research unit of this type would typically be funded through a combination of public research grants, industry-sponsored contract research, and possibly technology licensing, but none of these channels are confirmed in the input.
The absence of disclosed information is itself the most material finding for investment analysis purposes. Any strategic, financial, or commercial assessment of UCIBIO would require primary-source verification of its research output, funding sources, industry partnerships, and organizational affiliation before a defensible thesis can be constructed.
UCIBIO firmographics
Firmographics- Name
- UCIBIO
- Website
- https://ucibio.pt
- Company type
- Private
- Founded year
- 2015
- Headcount range
- 51–100 employees
- Short description
- UCIBIO is an applied molecular biosciences research unit based in Caparica, Portugal, founded in 2015, that conducts interdisciplinary research in chemistry, biology, and engineering to address applied problems in the molecular biosciences.
- Ownership category
- akta.pro rank
UCIBIO industry classification
Industry- Product category
- Biotechnology Research
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Synthetic Biology & Genetic Circuit Design Platforms (pathway engineering, chassis development) (HLAAAIAD)
- akta.pro secondary industries
- Clinical Research & Trial Central Laboratories (HLAFAMAL), Health & Biomedical Research Universities (Academic Medical Center–Affiliated) (EDAHABAC), Research Administration & Compliance (Sponsored Programs, IRB/REB) (EDADAKAH)
Keywords
Where UCIBIO is headquartered
LocationHeadquarters
- HQ city
- Caparica
- HQ country
- Portugal
- HQ region
- Europe
Markets served
UCIBIO business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations
UCIBIO product offering
Product offeringCore offering
UCIBIO is an applied molecular biosciences research unit that conducts research at the intersection of chemistry, biology, and engineering. The organization focuses on addressing relevant issues through integrated, interdisciplinary applied biosciences research activities.
Differentiator
Problem solved
Functional benefit
Products and services
- Applied Molecular Biosciences Research
Companies that use UCIBIO
Customer profileIdeal customer profiles1 record
UCIBIO technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
UCIBIO competitors and assessment
Company assessmentBroad incumbents
- European Molecular Biology Laboratory (EMBL): Intergovernmental European research organization in molecular life sciences. Comparable as a high-quality European applied molecular biosciences research platform, but operating at a much larger scale and with a primarily basic-research orientation.
- Novonesis (formerly Novozymes): Global industrial biotech and enzyme company with deep expertise in applied molecular biosciences for food, health, and environment. Comparable in the applied molecular-biology-to-industry axis, but far larger and commercially mature.
- Institut Pasteur: Large, established French research organization with deep programs in molecular biology, microbiology, and translational medicine. Comparable in being a multi-disciplinary life-sciences research institution, but much larger and broader in scope than UCIBIO.
Emerging players
- Ginkgo Bioworks: US-based synthetic biology and cell engineering platform serving industrial biotech applications. Comparable to UCIBIO's synthetic biology and molecular engineering work, but operating as a scaled commercial platform rather than an academic research unit.
Regional players
- Champalimaud Foundation (Research Programme): Lisbon-based research and clinical institution running programs in neuroscience and cancer biology with strong applied components. Comparable as a Portugal-based applied biomedical research organization, though with a clinical/translational rather than chemistry/engineering orientation.
- InBIO – Rede de Investigação em Biodiversidade e Biologia Evolutiva: Portuguese research network on biodiversity and evolutionary biology with an applied agenda. Comparable as a Portuguese applied life-sciences research network, but focused on biodiversity/ecology rather than the molecular biosciences core of UCIBIO.
Direct peers
- iBET (Instituto de Biologia Experimental e Tecnológica): Portugal-based non-profit research institute working on biotechnology, bioprocesses, and molecular biosciences with both academic and industry clients. It is the closest direct analogue to UCIBIO in geography, scope, and applied molecular biosciences focus.
- ITQB NOVA (Instituto de Tecnologia Química e Biológica António Xavier): A research institute at NOVA University Lisbon, also located in Oeiras/Caparica, conducting chemistry and biology research with applied biomedical and industrial biotechnology programs. It shares the same university ecosystem and overlapping research areas as UCIBIO.
- Centre for Genomic Regulation (CRG): Barcelona-based international biomedical research center covering genomics, systems biology, and molecular medicine. Comparable as a mid-sized European research institute with an applied bent in molecular biosciences.
- IBMC (Instituto de Biologia Molecular e Celular): Portuguese research institute affiliated with the University of Porto focused on molecular and cell biology, with strong applied and biomedical programs. It is comparable as a Portuguese academic research unit operating in the molecular biosciences space.
Market position
Strengths3 records
Weaknesses3 records
Competitive moat1 record
Key risks4 records
Key highlights4 records
Customer concentration
UCIBIO social profiles
Digital presenceUCIBIO financial estimates
Financial estimateRevenue estimate
Valuation estimate
UCIBIO leadership team
Management profileNumber of profiles
UCIBIO funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
UCIBIO M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about UCIBIO
What does UCIBIO do?
UCIBIO is an applied molecular biosciences research unit that conducts research at the intersection of chemistry, biology, and engineering. The organization focuses on addressing relevant issues through integrated, interdisciplinary applied biosciences research activities.
When was UCIBIO founded?
UCIBIO was founded in 2015. It employs 51 to 100 people.
Where is UCIBIO based?
UCIBIO is headquartered in Caparica, Portugal, in the Europe region.
Who are UCIBIO's main competitors?
Broad incumbents on record are European Molecular Biology Laboratory (EMBL), Novonesis (formerly Novozymes) and Institut Pasteur. Ginkgo Bioworks is listed as an emerging player. Regional players are Champalimaud Foundation (Research Programme) and InBIO – Rede de Investigação em Biodiversidade e Biologia Evolutiva. Direct peers are iBET (Instituto de Biologia Experimental e Tecnológica), ITQB NOVA (Instituto de Tecnologia Química e Biológica António Xavier), Centre for Genomic Regulation (CRG) and IBMC (Instituto de Biologia Molecular e Celular).
Does UCIBIO have an API?
No public API is recorded for UCIBIO.
What industry is UCIBIO in?
UCIBIO's product category is Biotechnology Research. Its primary akta.pro industry code is HLAAAIAD, Synthetic Biology & Genetic Circuit Design Platforms (pathway engineering, chassis development), with a secondary code of HLAFAMAL, Clinical Research & Trial Central Laboratories. Its NAICS code is 541714 and its SIC code is 8731.